Facile and Efficient Solid-Phase Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines

Abstract

The solid-phase synthesis of pyrrolo[2,1-c][1,4]benzodiazepines is described. Isatoic anhydrides attached to chloromethyl Wang resin are coupled with proline and the polymer-bound tricyclic compounds are reduced using very mild conditions, and successively cleaved from the resin to afford the desired imine-containing heterocyclic compounds. Reactions were monitored by FT-IR spectroscopy on the resin beads.

pyrrolo[2,1-c][1,4]benzodiazepines - solid-phase synthesis - chloromethyl Wang resin - isatoic anhydrides

References

1a Combinatorial Chemistry   Jung G. Wiley-VCH; Weinhein: 1998. 

1b Handbook of Combinatorial Chemistry   Nicolaou KC. Hanko R. Hartwig W. Wiley-VCH; Weinheim: 2002. 

1c Booth S. Hermkens PHH. Ottenheijm HCJ. Rees DC. Tetrahedron  1998,  54:  15385 

1d Sammelson RE. Kurth MJ. Chem. Rev.  2001,  101:  137 

1e Franzen RG. J. Comb. Chem.  2000,  2:  195 

2a Madden D. Krchnak V. Lebl M. Perspect. Drug Discovery Des.  1995,  2:  269 

2b Gordon EM. Barrett RW. Dower WJ. Fodor SPA. Gallop MA. J. Med. Chem.  1994,  37:  1385 

3a Krchnak V. Holladay MW. Chem. Rev.  2002,  102:  61 

3b Blaney P. Grigg R. Sridharan V. Chem. Rev.  2002,  102:  2607 

4 Thurston DE. In Molecular Aspects of Anticancer Drug-DNA Interactions   Neidle S. Waring MJ. Macmillan; London: 1993.  p.54 

5 Petrusek RL. Uhlenhopp EL. Duteau N. Hurley LH. J. Biol. Chem.  1982,  257:  6207 

6a Thurston DE. Bose DS. Chem. Rev.  1994,  94:  433 

6b Kamal A. Rao MV. Laxman N. Ramesh G. Reddy GSK. Curr. Med. Chem.: Anti-Cancer Agents  2002,  2:  215 

7 Gregson SJ. Howard PW. Hartley JA. Brooks AA. Adams LJ. Jenkins TC. Kelland LR. Thurston DE. J. Med. Chem.  2001,  44:  737 

8a Carbateas PM. inventors; US Patent,  3,732,212.  ; Chem. Abstr. 1973, 79, P42570x

8b Carbateas PM. inventors; US Patent,  3,763,183.  ; Chem. Abstr. 1973, 79, P146567t

8c Carbateas PM. inventors; US Patent,  3,860,600.  ; Chem. Abstr. 1975, 83, P58892x

9 Berry JM. Howard PW. Thurston DE. Tetrahedron Lett.  2000,  41:  6171 

10 Kamal A. Reddy GSK. Reddy KL. Raghavan S. Tetrahedron Lett.  2002,  43:  2103 

11 Kamal A. Reddy BSN. Reddy GSK. Synlett  1999,  1251 

12a Hu W.-P. Wang J.-J. Lin F.-L. Lin Y.-C. Lin S.-R. Hsu M.-H. J. Org. Chem.  2001,  66:  2881 

12b Mori M. Uozumi Y. Kimura M. Ban Y. Tetrahedron  1986,  42:  3793 

13 Raju B. Kogan TP. Tetrahedron Lett.  1997,  38:  4965 

14

Preparation of Compound 5a: The isatoic anhydride (1a, 0.815 g, 5 mmol) and NaH (0.12 g, 5 mmol) were taken in dry DMF (15 mL) and were stirred at r.t. for 1 h, followed by the addition of chloromethyl Wang resin (1 g, 1 mmol), which was allowed to stir at the same temperature for 24 h. The derivatized resin was filtered, rinsed with DMF (4×), CH₂Cl₂ (4×) and THF (2×), and dried in vacuo to give 1.115 g of 2a. The two C=O functional groups showed their absorption bands in the IR spectrum at 1782 cm^-1 and 1729 cm^-1. A mixture of isatoic resin (1.11 g) and l-proline (0.575 g, 5 mmol) in DMF (3 mL) at 50 °C was sonicated for 1 h to give polymer-bound PBD-5,11-dione (3a). Alternatively, this mixture in DMF (15 mL) was stirred at 100 °C for 8 h to give 3a. The resin was sequentially washed with DMF (4×), CH₂Cl₂ (4×), MeOH (4×), THF (4×) and dried in vacuo to give 1.10 g of 3a. These two C=O functional groups showed their absorption bands in the IR spectrum at 1748 cm^-1 and 1609 cm^-1. To a suspension of 3a (0.3 g) in dry THF (10 mL) at -10 °C was added LiBH₄ (0.021g, 1 mmol) in portions and stirred at -10 °C for 6 h. Alternatively, to a suspension of 3a (0.3 g) in MeOH-THF (7:3) at 0 °C was added NaBH₄ (0.037g, 1 mmol) in portions and stirred at 0 °C for 6 h. The resin 4a was filtered and rinsed with THF (4×), MeOH (4×), CH₂Cl₂ (4×) and MeOH (4×). One of the C=O band disappeared and an OH group appeared at 3400 cm^-1 while the C=O showed the absorption at 1611 cm^-1 in the IR spectrum. Finally, the product 4a was cleaved from the solid support using TFA-H₂O to yield the crude product 5a, which was further purified by column chromatography. ¹H NMR (200 MHz, CDCl₃): δ = 2.02-2.16 (2 H, m), 2.26-2.38 (2 H, m), 3.36-3.94 (3 H, m), 7.28-7.38 (2 H, m), 7.53 (1 H, t, J = 6.69 Hz), 7.79 (1 H, d, J = 4.46 Hz), 8.05 (1 H, d, J = 7.43 Hz). MS (EI): m/z = 200 [M⁺]; [α]_D ²⁶ +343 (c 0.4, CHCl₃) [lit. [16] [α]_D ²² +319 (c 0.147, CHCl₃)].

15

Preparation of Compound 6a: The suspension of 3a (0.5 g) in TFA-H₂O (9:1, 6 mL) was allowed to stir at r.t. for 4 h. The resin was filtered and washed with CH₂Cl₂ (3×). The combined filtrate was evaporated to afford the crude product (6a). This was further purified by column chromatography. ¹H NMR (200 MHz, CDCl₃): δ = 1.92-2.06 (3 H, m), 2.70-2.80 (1 H, m), 3.47-3.64 (1 H, m), 3.71-3.84 (1 H, m), 4.00-4.08 (1 H, m), 7.01 (1 H, d, J = 8.06 Hz), 7.22 (1 H, t, J = 7.32 Hz), 7.43 (1 H, t, J = 7.32 Hz), 7.95 (1 H, d, J = 8.06 Hz), 9.03 (1 H, s). MS (SI): m/z = 216 [M⁺]; [α]_D ²⁶ +489 (c 0.5, MeOH) [lit. [17] [α]_D ²⁵ +523 (c 1.0, MeOH)].

16 Lown JW. Joshua AV. Biochem. Pharmacol.  1979,  28:  2017 

17 Wright WB. Brabander HJ. Greenblatt EN. Day IP. Hardy RA. J. Med. Chem.  1978,  21:  1087